The Stroke Association is also a member of the Stroke Alliance for Europe (SAFE), a network of organisations that champion the voices of those affected by stroke. SAFE is currently involved in several European research projects. You can find out more about these projects hoping to improve treatment for stroke patients.
Funded by the European Union (EU), a new international study called PROOF will investigate whether high-dose oxygen therapy can reduce the effects of stroke.
The Stroke Association is a member of the Stroke Alliance For Europe (SAFE), which will work on communication of information about the PROOF trial to non-clinical audiences.
This research will help understand the role of the relationship between a stroke survivor and the health care professional to improve the outcomes of rehabilitation for the long-term.
Stroke is a global epidemic, in the UK alone someone will have a stroke every 3 and a half minutes.
The PRECIOUS project will examine the consequences of treating complications of stroke such as infections or fever or swallowing problems, all of which commonly occur in elderly patients. Failing to treat these complications often leads to a worse outcome overall.
The World Stroke Congress (WSC) is currently being held in Hyderabad, India (26-29 October 2016). The WSC leads up to World Stroke Day on 29 October 2016. Yesterday saw Stroke Support Organisations (SSOs) from across the world convene at its Stroke Support Organisation Conference, which helped kick off WSC proceedings. Our international Development Officer, Sarah Belson, leads our SSO work, and shared her expertise on how to set up and grow an SSO.
The number of strokes across the UK is likely to rise by almost half (44%) in the next 20 years, according to a new report published today by the Stroke Alliance for Europe (SAFE) and the Stroke Association.
How important is the relationship between therapist and stroke survivor in the rehabilitation of language ability?
STARR (stroke, technology and risk reduction) is a new research program, which will help stroke survivors manage their risk factors for recurrent stroke: a stroke that happens after someone has their first stroke.
Professor Joanna Wardlaw CBE talks about the new SVDs@target programme - Targeting interventions for small vessel disease to prevent stroke and dementia. This programme was funded by a 6 million euro grant from the European Union’s Horizon 2020 programme. Stroke Alliance for Europe (SAFE) is a key partner, representing stroke patient groups from across Europe, including the Stroke Association.